GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » FCF Yield %

Acerus Pharmaceuticals (TSX:ASP) FCF Yield % : 0.00 (As of Sep. 22, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Acerus Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Acerus Pharmaceuticals's Trailing 12-Month Free Cash Flow is C$-35.88 Mil, and Market Cap is C$2.78 Mil. Therefore, Acerus Pharmaceuticals's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Acerus Pharmaceuticals's FCF Yield % or its related term are showing as below:


TSX:ASP's FCF Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: -0.17
* Ranked among companies with meaningful FCF Yield % only.

Acerus Pharmaceuticals's FCF Margin % for the quarter that ended in Sep. 2022 was -1,074.20%.


Acerus Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Acerus Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acerus Pharmaceuticals FCF Yield % Chart

Acerus Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 -31.65 -72.44 -46.17 -78.55

Acerus Pharmaceuticals Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -42.46 -96.63 -39.11 -147.02 -309.47

Competitive Comparison of Acerus Pharmaceuticals's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Acerus Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acerus Pharmaceuticals's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acerus Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Acerus Pharmaceuticals's FCF Yield % falls into.



Acerus Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Acerus Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2021 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-30.194 / 38.4397
=-78.55%

Acerus Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Sep. 2022 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-11.032 * 4 / 14.259319
=-309.47%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acerus Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Acerus Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Acerus Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Acerus Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8
Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
Executives
Norma Beauchamp Director
Stephen Robert Gregory Director
Edward Joseph Gudaitis Director, Senior Officer

Acerus Pharmaceuticals Headlines